Clinical trials for Homozygous familial hypercholesterolemia
16 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGNCT07447648Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)
- RECRUITINGPhase 2NCT07489209A Dose-exploration Study of EDP167 in HoFHEddingpharm (Zhuhai) Co., Ltd. · PI: Kefei Dou, MD
- RECRUITINGPhase 3NCT07037771A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)Arrowhead Pharmaceuticals
- RECRUITINGN/ANCT06743659Computerized Decision Support for Identification and Management of Familial HypercholesterolemiaBrigham and Women's Hospital
- ACTIVE NOT RECRUITINGPhase 3NCT06712771A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of VSA003 in Chinese HoFH PatientsVisirna Therapeutics HK Limited
- ACTIVE NOT RECRUITINGNCT06832371Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial HypercholesterolemiaFondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)
- RECRUITINGEarly Phase 1NCT06458010Clinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH)RenJi Hospital
- ACTIVE NOT RECRUITINGNCT06275724Specified Drug-use Survey of Leqvio for s.c. Injection.Novartis Pharmaceuticals · PI: Novartis Pharmaceuticals
- RECRUITINGEarly Phase 1NCT06125847NGGT006 Gene Therapy for Homozygous Familial HypercholesterolemiaFirst Affiliated Hospital Xi'an Jiaotong University · PI: Zuyi Yuan, M.D.
- ACTIVE NOT RECRUITINGPhase 3NCT05682378Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Adolescent ORION-16 or ORION-13 StudiesNovartis Pharmaceuticals · PI: Novartis Pharmaceuticals
- ACTIVE NOT RECRUITINGPhase 2NCT05217667Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH)Arrowhead Pharmaceuticals
- ACTIVE NOT RECRUITINGPhase 3NCT05238519Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)Essentia Health
- RECRUITINGN/ANCT06571630PMMHRI - Familial Hypercholesterolemia RegistryPolish Mother Memorial Hospital Research Institute · PI: Maciej Banach, MD,PhD,FNLA,FAHA,FESC,FASA
- RECRUITINGNCT04815005HoFH, the International Clinical Collaborators RegistryUniversity of Pennsylvania · PI: Marina Cuchel, MD, PhD
- RECRUITINGNCT02135705LOWER: Lomitapide Observational Worldwide Evaluation RegistryAmryt Pharma · PI: Janet Boylan
- RECRUITINGNCT01109368The Rogosin Institute Homozygous Familial Hypercholesterolemia RepositoryThe Rogosin Institute · PI: Lisa C. Hudgins, M.D.